In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Todd Berard Biography and Net Worth

CMO of BioLife Solutions

Todd Berard was named Chief Marketing Officer at BioLife in December 2019. Todd joined BioLife as Senior Director of Marketing in 2014 and was promoted to Vice President the following year.

Before joining BioLife, Todd was Director of Marketing at Verathon Medical, a division of Roper Inc., from September 2010 until July 2014. In this capacity, Todd oversaw the creative and product management teams and was responsible for the global marketing, product development, and product launch strategies for a portfolio of six medical device brands. He also managed all strategic partnerships for product development and helped guide Verathon Medical through several key product launches and a corporate acquisition. His responsibilities included all global marketing initiatives and campaigns, strategy, product portfolio management, and strategic planning. Todd has over 20 years of experience in the life sciences, including health care, medical devices, and technology. He has worked for a wide range of entities, ranging from the University of Washington School of Medicine to DuPont, and Medtronic.

Todd has a Bachelor of Science Degree in Biochemistry from the University of Vermont and an MBA from the University of Washington Foster School of Business.

What is Todd Berard's net worth?: The estimated net worth of Todd Berard is at least $2.69 million as of November 12th, 2024. Mr. Berard owns 107,756 shares of BioLife Solutions stock worth more than $2,694,978 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Berard may own. Additionally, Mr. Berard receives a salary of $286,490.00 as CMO at BioLife Solutions. Learn More about Todd Berard's net worth.
How old is Todd Berard?: Mr. Berard is currently 55 years old. There are 6 older executives and no younger executives at BioLife Solutions. The oldest executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who is 64 years old. Learn More on Todd Berard's age.
What is Todd Berard's salary?: As the CMO of BioLife Solutions, Inc., Mr. Berard earns $286,490.00 per year. There are 4 executives that earn more than Mr. Berard. The highest earning executive at BioLife Solutions is Mr. Roderick de Greef, CEO & Chairman, who commands a salary of $1,630,000.00 per year. Learn More on Todd Berard's salary.
How do I contact Todd Berard?: The corporate mailing address for Mr. Berard and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Todd Berard's contact information.
Has Todd Berard been buying or selling shares of BioLife Solutions?: Over the course of the past ninety days, Todd Berard has sold $9,596.59 of BioLife Solutions stock. Most recently, Todd Berard sold 91 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $26.34, for a transaction totalling $2,396.94. Following the completion of the sale, the chief marketing officer now directly owns 107,756 shares of the company's stock, valued at $2,838,293.04. Learn More on Todd Berard's trading history.
Who are BioLife Solutions' active insiders?: BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.
Are insiders buying or selling shares of BioLife Solutions?: In the last twelve months, insiders at the medical equipment provider sold shares 75 times. They sold a total of 136,717 shares worth more than $2,703,077.70. The most recent insider tranaction occured on November, 18th when EVP Aby J Mathew sold 17,604 shares worth more than $352,960.20. Insiders at BioLife Solutions own 2.2% of the company. Learn More about insider trades at BioLife Solutions.
Information on this page was last updated on 11/18/2024.

Todd Berard Insider Trading History at BioLife Solutions

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Sell	91	$26.34	$2,396.94	107,756
10/30/2024	Sell	311	$23.15	$7,199.65	107,847
9/16/2024	Sell	367	$25.12	$9,219.04	108,158
8/21/2024	Sell	82	$25.61	$2,100.02	108,525
7/11/2024	Sell	287	$20.54	$5,894.98	108,607
6/14/2024	Sell	10,000	$20.18	$201,800.00	108,894
5/29/2024	Sell	345	$21.78	$7,514.10	118,894
5/17/2024	Sell	73	$22.18	$1,619.14	119,239
4/18/2024	Sell	332	$15.31	$5,082.92	129,312
4/15/2024	Sell	10,000	$15.67	$156,700.00	129,644
3/27/2024	Sell	515	$17.99	$9,264.85	139,644
3/11/2024	Sell	401	$17.42	$6,985.42	147,266
2/21/2024	Sell	111	$17.35	$1,925.85	115,688
1/19/2024	Sell	1,232	$16.76	$20,648.32	115,799
1/2/2024	Sell	491	$16.75	$8,224.25	117,031
12/1/2023	Sell	394	$12.37	$4,873.78	117,522
11/13/2023	Sell	98	$10.77	$1,055.46	117,916
9/28/2023	Sell	464	$14.16	$6,570.24	118,014
8/14/2023	Sell	134	$12.38	$1,658.92	118,825
6/27/2023	Sell	489	$22.91	$11,202.99	118,959
5/31/2023	Sell	337	$23.21	$7,821.77	119,448
5/15/2023	Sell	92	$18.71	$1,721.32	119,785
4/6/2023	Sell	1,545	$20.03	$30,946.35	116,267
3/29/2023	Sell	521	$20.62	$10,743.02	117,812
3/1/2023	Sell	874	$22.75	$19,883.50	118,333
2/8/2023	Sell	9,000	$25.13	$226,170.00	119,265
1/23/2023	Sell	3,500	$25.01	$87,535.00	119,265
1/18/2023	Sell	6,500	$25.04	$162,760.00	119,265
12/28/2022	Sell	501	$16.90	$8,466.90	107,380
11/10/2022	Sell	50	$23.16	$1,158.00	107,881
9/29/2022	Sell	463	$23.02	$10,658.26	107,931
8/10/2022	Sell	52	$23.17	$1,204.84	108,394
6/28/2022	Sell	495	$14.86	$7,355.70	108,446
5/13/2022	Sell	51	$12.32	$628.32	108,941
4/18/2022	Sell	13,581	$17.59	$238,889.79	108,992
3/29/2022	Sell	475	$22.24	$10,564.00
2/10/2022	Sell	254	$29.38	$7,462.52
12/29/2021	Sell	517	$39.37	$20,354.29
11/15/2021	Sell	6,160	$47.96	$295,433.60
10/15/2021	Sell	6,160	$40.76	$251,081.60
9/28/2021	Sell	505	$43.12	$21,775.60
9/15/2021	Sell	6,160	$49.01	$301,901.60
8/17/2021	Sell	6,160	$44.80	$275,968.00	85,224
7/15/2021	Sell	6,165	$42.74	$263,492.10
6/15/2021	Sell	6,160	$39.38	$242,580.80	85,726
5/14/2021	Sell	6,160	$29.68	$182,828.80	85,726
4/16/2021	Sell	6,160	$33.38	$205,620.80	85,726
4/1/2021	Sell	2,825	$36.53	$103,197.25	80,029
3/26/2021	Sell	2,120	$35.01	$74,221.20	72,750
3/16/2021	Sell	6,160	$36.72	$226,195.20	81,030
2/18/2021	Sell	1,882	$40.67	$76,540.94	67,488
2/16/2021	Sell	12,324	$44.48	$548,171.52	70,042
11/13/2020	Sell	5,000	$32.16	$160,800.00	69,878
9/29/2020	Sell	808	$28.63	$23,133.04	63,878
12/16/2019	Sell	3,000	$15.68	$47,040.00	44,074
11/14/2019	Sell	3,000	$14.06	$42,180.00	44,074
9/16/2019	Sell	3,000	$20.02	$60,060.00	44,074
8/15/2019	Sell	3,000	$17.97	$53,910.00	44,074
7/15/2019	Sell	3,000	$16.58	$49,740.00	44,074
6/17/2019	Sell	3,000	$17.47	$52,410.00	44,074
5/15/2019	Sell	3,000	$16.96	$50,880.00	44,074
4/15/2019	Sell	3,000	$17.56	$52,680.00	44,074
3/14/2019	Sell	3,000	$16.67	$50,010.00	44,074
2/14/2019	Sell	3,000	$16.07	$48,210.00	37,583
1/15/2019	Sell	3,000	$12.12	$36,360.00	37,583
9/21/2018	Sell	3,000	$17.23	$51,690.00	37,583

Todd Berard Buying and Selling Activity at BioLife Solutions

BioLife Solutions Company Overview

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Today's Range

Now: $25.01

$21.90

$25.11

50 Day Range

MA: $23.96

$20.47

$26.60

2 Week Range

Now: $25.01

$11.91

$28.88

Volume

926,418 shs

Average Volume

385,125 shs

Market Capitalization

$1.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Todd Berard Biography and Net Worth

What is Todd Berard's net worth?

How old is Todd Berard?

What is Todd Berard's salary?

How do I contact Todd Berard?

Has Todd Berard been buying or selling shares of BioLife Solutions?

Who are BioLife Solutions' active insiders?

Are insiders buying or selling shares of BioLife Solutions?